Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma

Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma

Purpose: To investigate the predictive values of plasma Epstein-Barr Virus (EBV)- deoxyribonucleic acid (DNA) copy number on disease progression and survival in stage I-III pulmonary lymphoepithelioma-like carcinoma (LELC).Patients and Methods: Patients with pathologically confirmed, initially diagn...

Full description

Bibliographic Details
Main Authors: Qi-Wen Li, Bo Qiu, Wan-Ming Hu, Su-Ping Guo, Ying-Jia Wu, Yu-Jia Zhu, Nan Hu, Xin-Lei Ai, Nai-Bin Chen, Jin-Yu Guo, Yong-Hong Hu, Meng-Zhong Liu, Mu-Sheng Zeng, Hui Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
pulmonary lymphoepithelioma-like carcinoma
Epstein-Barr virus
biomarker
tumor progression
monitoring
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01487/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01487/full

Similar Items